nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—ADA—pleura—sarcoma	0.128	0.269	CbGeAlD
Adenosine—Adenosine monophosphate—CREB1—sarcoma	0.0176	0.712	CrCbGaD
Adenosine—ADK—mammary gland—sarcoma	0.0155	0.0327	CbGeAlD
Adenosine—ADA—myometrium—sarcoma	0.0135	0.0284	CbGeAlD
Adenosine—ADA—hematopoietic system—sarcoma	0.0116	0.0244	CbGeAlD
Adenosine—SLC28A3—bone marrow—sarcoma	0.0114	0.024	CbGeAlD
Adenosine—ADORA2B—smooth muscle tissue—sarcoma	0.0112	0.0235	CbGeAlD
Adenosine—ADA—connective tissue—sarcoma	0.0112	0.0235	CbGeAlD
Adenosine—ADK—myometrium—sarcoma	0.011	0.0232	CbGeAlD
Adenosine—ADORA2A—hematopoietic system—sarcoma	0.0105	0.0222	CbGeAlD
Adenosine—DPP4—embryo—sarcoma	0.0103	0.0217	CbGeAlD
Adenosine—ADK—seminal vesicle—sarcoma	0.00997	0.021	CbGeAlD
Adenosine—DPP4—seminal vesicle—sarcoma	0.00966	0.0203	CbGeAlD
Adenosine—ADK—hematopoietic system—sarcoma	0.00947	0.0199	CbGeAlD
Adenosine—DPP4—hematopoietic system—sarcoma	0.00919	0.0193	CbGeAlD
Adenosine—ADORA1—hematopoietic system—sarcoma	0.00911	0.0192	CbGeAlD
Adenosine—DPP4—connective tissue—sarcoma	0.00884	0.0186	CbGeAlD
Adenosine—ADK—smooth muscle tissue—sarcoma	0.00834	0.0176	CbGeAlD
Adenosine—ADK—skin of body—sarcoma	0.00824	0.0173	CbGeAlD
Adenosine—ADA—lymphoid tissue—sarcoma	0.00816	0.0172	CbGeAlD
Adenosine—DPP4—smooth muscle tissue—sarcoma	0.00809	0.017	CbGeAlD
Adenosine—ADA—tendon—sarcoma	0.00767	0.0162	CbGeAlD
Adenosine—ADA—bone marrow—sarcoma	0.00743	0.0156	CbGeAlD
Adenosine—ADORA2A—lymphoid tissue—sarcoma	0.00743	0.0156	CbGeAlD
Adenosine—ADK—cardiac atrium—sarcoma	0.00719	0.0151	CbGeAlD
Adenosine—Adenosine monophosphate—SRC—sarcoma	0.00712	0.288	CrCbGaD
Adenosine—ADORA2B—testis—sarcoma	0.00695	0.0146	CbGeAlD
Adenosine—DPP4—uterus—sarcoma	0.00694	0.0146	CbGeAlD
Adenosine—ADORA1—cardiac atrium—sarcoma	0.00692	0.0146	CbGeAlD
Adenosine—ADK—lymphoid tissue—sarcoma	0.00667	0.014	CbGeAlD
Adenosine—DPP4—lymphoid tissue—sarcoma	0.00647	0.0136	CbGeAlD
Adenosine—ADA—testis—sarcoma	0.00635	0.0134	CbGeAlD
Adenosine—ADK—tendon—sarcoma	0.00627	0.0132	CbGeAlD
Adenosine—DPP4—tendon—sarcoma	0.00608	0.0128	CbGeAlD
Adenosine—ADK—bone marrow—sarcoma	0.00607	0.0128	CbGeAlD
Adenosine—ADORA1—tendon—sarcoma	0.00603	0.0127	CbGeAlD
Adenosine—DPP4—bone marrow—sarcoma	0.00589	0.0124	CbGeAlD
Adenosine—ADORA2A—testis—sarcoma	0.00578	0.0122	CbGeAlD
Adenosine—ADORA2A—liver—sarcoma	0.00547	0.0115	CbGeAlD
Adenosine—ADK—testis—sarcoma	0.00519	0.0109	CbGeAlD
Adenosine—DPP4—testis—sarcoma	0.00503	0.0106	CbGeAlD
Adenosine—ADORA1—testis—sarcoma	0.00499	0.0105	CbGeAlD
Adenosine—ADK—liver—sarcoma	0.00491	0.0103	CbGeAlD
Adenosine—Apnoea—Etoposide—sarcoma	0.00478	0.00955	CcSEcCtD
Adenosine—DPP4—liver—sarcoma	0.00476	0.01	CbGeAlD
Adenosine—Sensory loss—Etoposide—sarcoma	0.00467	0.00935	CcSEcCtD
Adenosine—ADA—lymph node—sarcoma	0.00461	0.00969	CbGeAlD
Adenosine—Chest discomfort—Etoposide—sarcoma	0.00458	0.00915	CcSEcCtD
Adenosine—Cardiac failure—Thiotepa—sarcoma	0.00419	0.00838	CcSEcCtD
Adenosine—Cardiac arrest—Thiotepa—sarcoma	0.00389	0.00778	CcSEcCtD
Adenosine—ADK—lymph node—sarcoma	0.00376	0.00792	CbGeAlD
Adenosine—DPP4—lymph node—sarcoma	0.00365	0.00768	CbGeAlD
Adenosine—Cardiac failure—Mitoxantrone—sarcoma	0.00362	0.00724	CcSEcCtD
Adenosine—ADORA1—lymph node—sarcoma	0.00362	0.00761	CbGeAlD
Adenosine—Cardiac arrest—Vincristine—sarcoma	0.00345	0.0069	CcSEcCtD
Adenosine—Hyperventilation—Epirubicin—sarcoma	0.0033	0.0066	CcSEcCtD
Adenosine—Burning sensation—Epirubicin—sarcoma	0.00327	0.00653	CcSEcCtD
Adenosine—Ventricular arrhythmia—Epirubicin—sarcoma	0.00307	0.00613	CcSEcCtD
Adenosine—Hyperventilation—Doxorubicin—sarcoma	0.00305	0.0061	CcSEcCtD
Adenosine—Burning sensation—Doxorubicin—sarcoma	0.00302	0.00604	CcSEcCtD
Adenosine—Cardiac failure—Etoposide—sarcoma	0.00301	0.00602	CcSEcCtD
Adenosine—Scotoma—Epirubicin—sarcoma	0.00299	0.00598	CcSEcCtD
Adenosine—Ventricular arrhythmia—Doxorubicin—sarcoma	0.00284	0.00567	CcSEcCtD
Adenosine—Cardiac arrest—Etoposide—sarcoma	0.0028	0.00559	CcSEcCtD
Adenosine—Scotoma—Doxorubicin—sarcoma	0.00277	0.00553	CcSEcCtD
Adenosine—Acute coronary syndrome—Vincristine—sarcoma	0.00276	0.00551	CcSEcCtD
Adenosine—Myocardial infarction—Vincristine—sarcoma	0.00274	0.00548	CcSEcCtD
Adenosine—Drowsiness—Mitoxantrone—sarcoma	0.00272	0.00545	CcSEcCtD
Adenosine—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00268	0.00537	CcSEcCtD
Adenosine—Sweating—Vincristine—sarcoma	0.00268	0.00536	CcSEcCtD
Adenosine—Myocardial infarction—Mitoxantrone—sarcoma	0.00267	0.00534	CcSEcCtD
Adenosine—Tinnitus—Thiotepa—sarcoma	0.00264	0.00528	CcSEcCtD
Adenosine—Cardiac disorder—Thiotepa—sarcoma	0.00263	0.00525	CcSEcCtD
Adenosine—Sweating—Mitoxantrone—sarcoma	0.00261	0.00522	CcSEcCtD
Adenosine—Flushing—Dactinomycin—sarcoma	0.00261	0.00521	CcSEcCtD
Adenosine—Mediastinal disorder—Thiotepa—sarcoma	0.00255	0.0051	CcSEcCtD
Adenosine—Arrhythmia—Thiotepa—sarcoma	0.00253	0.00506	CcSEcCtD
Adenosine—Ventricular extrasystoles—Epirubicin—sarcoma	0.00251	0.00503	CcSEcCtD
Adenosine—Bronchospasm—Etoposide—sarcoma	0.0025	0.005	CcSEcCtD
Adenosine—Hypoaesthesia—Vincristine—sarcoma	0.0025	0.00499	CcSEcCtD
Adenosine—Bradycardia—Mitoxantrone—sarcoma	0.00249	0.00498	CcSEcCtD
Adenosine—Tension—Thiotepa—sarcoma	0.00242	0.00484	CcSEcCtD
Adenosine—Nervousness—Thiotepa—sarcoma	0.00239	0.00479	CcSEcCtD
Adenosine—Back pain—Thiotepa—sarcoma	0.00238	0.00477	CcSEcCtD
Adenosine—Atrioventricular block—Epirubicin—sarcoma	0.00234	0.00468	CcSEcCtD
Adenosine—Cardiac disorder—Vincristine—sarcoma	0.00233	0.00466	CcSEcCtD
Adenosine—Ventricular extrasystoles—Doxorubicin—sarcoma	0.00233	0.00465	CcSEcCtD
Adenosine—Vision blurred—Thiotepa—sarcoma	0.00232	0.00464	CcSEcCtD
Adenosine—Ventricular tachycardia—Epirubicin—sarcoma	0.00227	0.00454	CcSEcCtD
Adenosine—Agitation—Thiotepa—sarcoma	0.00226	0.00453	CcSEcCtD
Adenosine—Mediastinal disorder—Vincristine—sarcoma	0.00226	0.00452	CcSEcCtD
Adenosine—Injection site reaction—Epirubicin—sarcoma	0.00226	0.00451	CcSEcCtD
Adenosine—Acute coronary syndrome—Etoposide—sarcoma	0.00223	0.00447	CcSEcCtD
Adenosine—Myocardial infarction—Etoposide—sarcoma	0.00222	0.00444	CcSEcCtD
Adenosine—Arrhythmia—Mitoxantrone—sarcoma	0.00218	0.00437	CcSEcCtD
Adenosine—Atrioventricular block—Doxorubicin—sarcoma	0.00217	0.00433	CcSEcCtD
Adenosine—Cough—Thiotepa—sarcoma	0.00215	0.0043	CcSEcCtD
Adenosine—Convulsion—Thiotepa—sarcoma	0.00214	0.00427	CcSEcCtD
Adenosine—Hypertension—Thiotepa—sarcoma	0.00213	0.00425	CcSEcCtD
Adenosine—Back pain—Vincristine—sarcoma	0.00211	0.00423	CcSEcCtD
Adenosine—Ventricular tachycardia—Doxorubicin—sarcoma	0.0021	0.0042	CcSEcCtD
Adenosine—Anxiety—Thiotepa—sarcoma	0.00209	0.00418	CcSEcCtD
Adenosine—Injection site reaction—Doxorubicin—sarcoma	0.00209	0.00417	CcSEcCtD
Adenosine—Dysgeusia—Mitoxantrone—sarcoma	0.00208	0.00417	CcSEcCtD
Adenosine—Back pain—Mitoxantrone—sarcoma	0.00206	0.00412	CcSEcCtD
Adenosine—Discomfort—Dactinomycin—sarcoma	0.00206	0.00411	CcSEcCtD
Adenosine—Hypoaesthesia—Etoposide—sarcoma	0.00202	0.00405	CcSEcCtD
Adenosine—Agitation—Vincristine—sarcoma	0.00201	0.00402	CcSEcCtD
Adenosine—Vision blurred—Mitoxantrone—sarcoma	0.00201	0.00401	CcSEcCtD
Adenosine—Tachycardia—Thiotepa—sarcoma	0.00196	0.00393	CcSEcCtD
Adenosine—Convulsion—Vincristine—sarcoma	0.00189	0.00379	CcSEcCtD
Adenosine—Cardiac disorder—Etoposide—sarcoma	0.00189	0.00377	CcSEcCtD
Adenosine—Flushing—Etoposide—sarcoma	0.00189	0.00377	CcSEcCtD
Adenosine—Hypertension—Vincristine—sarcoma	0.00189	0.00377	CcSEcCtD
Adenosine—Cough—Mitoxantrone—sarcoma	0.00186	0.00371	CcSEcCtD
Adenosine—Convulsion—Mitoxantrone—sarcoma	0.00184	0.00369	CcSEcCtD
Adenosine—Hypertension—Mitoxantrone—sarcoma	0.00184	0.00367	CcSEcCtD
Adenosine—Mediastinal disorder—Etoposide—sarcoma	0.00183	0.00366	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00183	0.00366	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00182	0.00364	CcSEcCtD
Adenosine—Chest pain—Mitoxantrone—sarcoma	0.00181	0.00362	CcSEcCtD
Adenosine—Paraesthesia—Thiotepa—sarcoma	0.00181	0.00361	CcSEcCtD
Adenosine—Anxiety—Mitoxantrone—sarcoma	0.00181	0.00361	CcSEcCtD
Adenosine—Discomfort—Mitoxantrone—sarcoma	0.00179	0.00358	CcSEcCtD
Adenosine—Somnolence—Thiotepa—sarcoma	0.00179	0.00358	CcSEcCtD
Adenosine—Anaphylactic shock—Vincristine—sarcoma	0.00178	0.00357	CcSEcCtD
Adenosine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00174	0.00347	CcSEcCtD
Adenosine—Dysgeusia—Etoposide—sarcoma	0.00173	0.00347	CcSEcCtD
Adenosine—Hyperhidrosis—Vincristine—sarcoma	0.00172	0.00345	CcSEcCtD
Adenosine—Pain—Thiotepa—sarcoma	0.00172	0.00344	CcSEcCtD
Adenosine—Back pain—Etoposide—sarcoma	0.00171	0.00342	CcSEcCtD
Adenosine—Shock—Mitoxantrone—sarcoma	0.00171	0.00342	CcSEcCtD
Adenosine—Pain—Dactinomycin—sarcoma	0.00171	0.00341	CcSEcCtD
Adenosine—Tachycardia—Mitoxantrone—sarcoma	0.0017	0.00339	CcSEcCtD
Adenosine—Cardiac failure—Epirubicin—sarcoma	0.00169	0.00338	CcSEcCtD
Adenosine—Cerebrovascular accident—Epirubicin—sarcoma	0.00168	0.00336	CcSEcCtD
Adenosine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00168	0.00336	CcSEcCtD
Adenosine—Hypotension—Vincristine—sarcoma	0.00167	0.00333	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00162	0.00325	CcSEcCtD
Adenosine—Hypotension—Mitoxantrone—sarcoma	0.00162	0.00325	CcSEcCtD
Adenosine—Affect lability—Epirubicin—sarcoma	0.00162	0.00324	CcSEcCtD
Adenosine—Paraesthesia—Vincristine—sarcoma	0.0016	0.0032	CcSEcCtD
Adenosine—Urticaria—Thiotepa—sarcoma	0.0016	0.00319	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00158	0.00316	CcSEcCtD
Adenosine—Cardiac arrest—Epirubicin—sarcoma	0.00157	0.00313	CcSEcCtD
Adenosine—Cardiac failure—Doxorubicin—sarcoma	0.00156	0.00312	CcSEcCtD
Adenosine—Mood swings—Epirubicin—sarcoma	0.00156	0.00312	CcSEcCtD
Adenosine—Paraesthesia—Mitoxantrone—sarcoma	0.00156	0.00312	CcSEcCtD
Adenosine—Loss of consciousness—Etoposide—sarcoma	0.00156	0.00311	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—sarcoma	0.00156	0.00311	CcSEcCtD
Adenosine—Dyspnoea—Mitoxantrone—sarcoma	0.00155	0.0031	CcSEcCtD
Adenosine—Cough—Etoposide—sarcoma	0.00154	0.00309	CcSEcCtD
Adenosine—Somnolence—Mitoxantrone—sarcoma	0.00154	0.00309	CcSEcCtD
Adenosine—Convulsion—Etoposide—sarcoma	0.00153	0.00307	CcSEcCtD
Adenosine—Hypertension—Etoposide—sarcoma	0.00153	0.00306	CcSEcCtD
Adenosine—Pain—Vincristine—sarcoma	0.00153	0.00305	CcSEcCtD
Adenosine—Chest pain—Etoposide—sarcoma	0.00151	0.00301	CcSEcCtD
Adenosine—Affect lability—Doxorubicin—sarcoma	0.0015	0.003	CcSEcCtD
Adenosine—Discomfort—Etoposide—sarcoma	0.00149	0.00298	CcSEcCtD
Adenosine—Pain—Mitoxantrone—sarcoma	0.00149	0.00297	CcSEcCtD
Adenosine—Hypersensitivity—Thiotepa—sarcoma	0.00148	0.00296	CcSEcCtD
Adenosine—Hypersensitivity—Dactinomycin—sarcoma	0.00147	0.00294	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—sarcoma	0.00145	0.0029	CcSEcCtD
Adenosine—Anaphylactic shock—Etoposide—sarcoma	0.00144	0.00289	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—sarcoma	0.00144	0.00289	CcSEcCtD
Adenosine—Asthenia—Thiotepa—sarcoma	0.00144	0.00289	CcSEcCtD
Adenosine—Asthenia—Dactinomycin—sarcoma	0.00143	0.00286	CcSEcCtD
Adenosine—Tachycardia—Etoposide—sarcoma	0.00141	0.00282	CcSEcCtD
Adenosine—Hyperhidrosis—Etoposide—sarcoma	0.0014	0.00279	CcSEcCtD
Adenosine—Urticaria—Mitoxantrone—sarcoma	0.00138	0.00276	CcSEcCtD
Adenosine—Hypotension—Etoposide—sarcoma	0.00135	0.0027	CcSEcCtD
Adenosine—Dizziness—Thiotepa—sarcoma	0.00133	0.00266	CcSEcCtD
Adenosine—Pollakiuria—Epirubicin—sarcoma	0.00132	0.00263	CcSEcCtD
Adenosine—Hypersensitivity—Vincristine—sarcoma	0.00131	0.00263	CcSEcCtD
Adenosine—Paraesthesia—Etoposide—sarcoma	0.0013	0.00259	CcSEcCtD
Adenosine—Dyspnoea—Etoposide—sarcoma	0.00129	0.00258	CcSEcCtD
Adenosine—Somnolence—Etoposide—sarcoma	0.00128	0.00257	CcSEcCtD
Adenosine—Hypersensitivity—Mitoxantrone—sarcoma	0.00128	0.00256	CcSEcCtD
Adenosine—Asthenia—Vincristine—sarcoma	0.00128	0.00256	CcSEcCtD
Adenosine—Vomiting—Thiotepa—sarcoma	0.00128	0.00256	CcSEcCtD
Adenosine—Drowsiness—Epirubicin—sarcoma	0.00127	0.00254	CcSEcCtD
Adenosine—Vomiting—Dactinomycin—sarcoma	0.00127	0.00254	CcSEcCtD
Adenosine—Rash—Thiotepa—sarcoma	0.00127	0.00254	CcSEcCtD
Adenosine—Dermatitis—Thiotepa—sarcoma	0.00127	0.00253	CcSEcCtD
Adenosine—Headache—Thiotepa—sarcoma	0.00126	0.00252	CcSEcCtD
Adenosine—Rash—Dactinomycin—sarcoma	0.00126	0.00252	CcSEcCtD
Adenosine—Asthenia—Mitoxantrone—sarcoma	0.00125	0.00249	CcSEcCtD
Adenosine—Pain—Etoposide—sarcoma	0.00124	0.00247	CcSEcCtD
Adenosine—Sweating—Epirubicin—sarcoma	0.00122	0.00243	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—sarcoma	0.00122	0.00243	CcSEcCtD
Adenosine—Nausea—Thiotepa—sarcoma	0.00119	0.00239	CcSEcCtD
Adenosine—Nausea—Dactinomycin—sarcoma	0.00119	0.00237	CcSEcCtD
Adenosine—Dizziness—Vincristine—sarcoma	0.00118	0.00236	CcSEcCtD
Adenosine—Drowsiness—Doxorubicin—sarcoma	0.00117	0.00235	CcSEcCtD
Adenosine—Bradycardia—Epirubicin—sarcoma	0.00116	0.00232	CcSEcCtD
Adenosine—Urticaria—Etoposide—sarcoma	0.00115	0.00229	CcSEcCtD
Adenosine—Hypoaesthesia—Epirubicin—sarcoma	0.00113	0.00227	CcSEcCtD
Adenosine—Vomiting—Vincristine—sarcoma	0.00113	0.00227	CcSEcCtD
Adenosine—Sweating—Doxorubicin—sarcoma	0.00113	0.00225	CcSEcCtD
Adenosine—Rash—Vincristine—sarcoma	0.00112	0.00225	CcSEcCtD
Adenosine—Dermatitis—Vincristine—sarcoma	0.00112	0.00225	CcSEcCtD
Adenosine—Headache—Vincristine—sarcoma	0.00112	0.00223	CcSEcCtD
Adenosine—Vomiting—Mitoxantrone—sarcoma	0.0011	0.00221	CcSEcCtD
Adenosine—Rash—Mitoxantrone—sarcoma	0.0011	0.00219	CcSEcCtD
Adenosine—Dermatitis—Mitoxantrone—sarcoma	0.00109	0.00219	CcSEcCtD
Adenosine—Headache—Mitoxantrone—sarcoma	0.00109	0.00218	CcSEcCtD
Adenosine—Bradycardia—Doxorubicin—sarcoma	0.00107	0.00215	CcSEcCtD
Adenosine—Hypersensitivity—Etoposide—sarcoma	0.00106	0.00213	CcSEcCtD
Adenosine—Tinnitus—Epirubicin—sarcoma	0.00106	0.00213	CcSEcCtD
Adenosine—Nausea—Vincristine—sarcoma	0.00106	0.00212	CcSEcCtD
Adenosine—Cardiac disorder—Epirubicin—sarcoma	0.00106	0.00212	CcSEcCtD
Adenosine—Flushing—Epirubicin—sarcoma	0.00106	0.00212	CcSEcCtD
Adenosine—Hypoaesthesia—Doxorubicin—sarcoma	0.00105	0.0021	CcSEcCtD
Adenosine—Asthenia—Etoposide—sarcoma	0.00104	0.00207	CcSEcCtD
Adenosine—Nausea—Mitoxantrone—sarcoma	0.00103	0.00206	CcSEcCtD
Adenosine—Mediastinal disorder—Epirubicin—sarcoma	0.00103	0.00205	CcSEcCtD
Adenosine—Arrhythmia—Epirubicin—sarcoma	0.00102	0.00204	CcSEcCtD
Adenosine—Tinnitus—Doxorubicin—sarcoma	0.000983	0.00197	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—sarcoma	0.000979	0.00196	CcSEcCtD
Adenosine—Flushing—Doxorubicin—sarcoma	0.000979	0.00196	CcSEcCtD
Adenosine—Tension—Epirubicin—sarcoma	0.000974	0.00195	CcSEcCtD
Adenosine—Dysgeusia—Epirubicin—sarcoma	0.000972	0.00194	CcSEcCtD
Adenosine—Nervousness—Epirubicin—sarcoma	0.000964	0.00193	CcSEcCtD
Adenosine—Back pain—Epirubicin—sarcoma	0.00096	0.00192	CcSEcCtD
Adenosine—Dizziness—Etoposide—sarcoma	0.000955	0.00191	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—sarcoma	0.000951	0.0019	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—sarcoma	0.000942	0.00188	CcSEcCtD
Adenosine—Vision blurred—Epirubicin—sarcoma	0.000935	0.00187	CcSEcCtD
Adenosine—Vomiting—Etoposide—sarcoma	0.000919	0.00184	CcSEcCtD
Adenosine—Agitation—Epirubicin—sarcoma	0.000912	0.00182	CcSEcCtD
Adenosine—Rash—Etoposide—sarcoma	0.000911	0.00182	CcSEcCtD
Adenosine—Dermatitis—Etoposide—sarcoma	0.00091	0.00182	CcSEcCtD
Adenosine—Headache—Etoposide—sarcoma	0.000905	0.00181	CcSEcCtD
Adenosine—Tension—Doxorubicin—sarcoma	0.000901	0.0018	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—sarcoma	0.000899	0.0018	CcSEcCtD
Adenosine—Nervousness—Doxorubicin—sarcoma	0.000892	0.00178	CcSEcCtD
Adenosine—Syncope—Epirubicin—sarcoma	0.00089	0.00178	CcSEcCtD
Adenosine—Back pain—Doxorubicin—sarcoma	0.000888	0.00178	CcSEcCtD
Adenosine—Palpitations—Epirubicin—sarcoma	0.000877	0.00175	CcSEcCtD
Adenosine—Loss of consciousness—Epirubicin—sarcoma	0.000872	0.00174	CcSEcCtD
Adenosine—Cough—Epirubicin—sarcoma	0.000866	0.00173	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—sarcoma	0.000865	0.00173	CcSEcCtD
Adenosine—Convulsion—Epirubicin—sarcoma	0.00086	0.00172	CcSEcCtD
Adenosine—Nausea—Etoposide—sarcoma	0.000858	0.00172	CcSEcCtD
Adenosine—Hypertension—Epirubicin—sarcoma	0.000857	0.00171	CcSEcCtD
Adenosine—Chest pain—Epirubicin—sarcoma	0.000845	0.00169	CcSEcCtD
Adenosine—Agitation—Doxorubicin—sarcoma	0.000844	0.00169	CcSEcCtD
Adenosine—Anxiety—Epirubicin—sarcoma	0.000842	0.00168	CcSEcCtD
Adenosine—Discomfort—Epirubicin—sarcoma	0.000835	0.00167	CcSEcCtD
Adenosine—Dry mouth—Epirubicin—sarcoma	0.000826	0.00165	CcSEcCtD
Adenosine—Syncope—Doxorubicin—sarcoma	0.000823	0.00165	CcSEcCtD
Adenosine—Palpitations—Doxorubicin—sarcoma	0.000811	0.00162	CcSEcCtD
Adenosine—Anaphylactic shock—Epirubicin—sarcoma	0.00081	0.00162	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—sarcoma	0.000807	0.00161	CcSEcCtD
Adenosine—Cough—Doxorubicin—sarcoma	0.000801	0.0016	CcSEcCtD
Adenosine—Shock—Epirubicin—sarcoma	0.000797	0.00159	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—sarcoma	0.000796	0.00159	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—sarcoma	0.000793	0.00159	CcSEcCtD
Adenosine—Tachycardia—Epirubicin—sarcoma	0.00079	0.00158	CcSEcCtD
Adenosine—Hyperhidrosis—Epirubicin—sarcoma	0.000783	0.00157	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—sarcoma	0.000782	0.00156	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—sarcoma	0.000779	0.00156	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—sarcoma	0.000772	0.00154	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—sarcoma	0.000765	0.00153	CcSEcCtD
Adenosine—Hypotension—Epirubicin—sarcoma	0.000757	0.00151	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—sarcoma	0.000749	0.0015	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000738	0.00148	CcSEcCtD
Adenosine—Shock—Doxorubicin—sarcoma	0.000737	0.00147	CcSEcCtD
Adenosine—Tachycardia—Doxorubicin—sarcoma	0.000731	0.00146	CcSEcCtD
Adenosine—Paraesthesia—Epirubicin—sarcoma	0.000727	0.00145	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—sarcoma	0.000724	0.00145	CcSEcCtD
Adenosine—Dyspnoea—Epirubicin—sarcoma	0.000722	0.00144	CcSEcCtD
Adenosine—Somnolence—Epirubicin—sarcoma	0.00072	0.00144	CcSEcCtD
Adenosine—Hypotension—Doxorubicin—sarcoma	0.0007	0.0014	CcSEcCtD
Adenosine—Pain—Epirubicin—sarcoma	0.000693	0.00138	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000683	0.00137	CcSEcCtD
Adenosine—Paraesthesia—Doxorubicin—sarcoma	0.000673	0.00135	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—sarcoma	0.000668	0.00134	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—sarcoma	0.000666	0.00133	CcSEcCtD
Adenosine—Urticaria—Epirubicin—sarcoma	0.000643	0.00129	CcSEcCtD
Adenosine—Pain—Doxorubicin—sarcoma	0.000641	0.00128	CcSEcCtD
Adenosine—Hypersensitivity—Epirubicin—sarcoma	0.000597	0.00119	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—sarcoma	0.000595	0.00119	CcSEcCtD
Adenosine—Asthenia—Epirubicin—sarcoma	0.000581	0.00116	CcSEcCtD
Adenosine—Hypersensitivity—Doxorubicin—sarcoma	0.000552	0.0011	CcSEcCtD
Adenosine—Asthenia—Doxorubicin—sarcoma	0.000538	0.00108	CcSEcCtD
Adenosine—Dizziness—Epirubicin—sarcoma	0.000536	0.00107	CcSEcCtD
Adenosine—Vomiting—Epirubicin—sarcoma	0.000515	0.00103	CcSEcCtD
Adenosine—Rash—Epirubicin—sarcoma	0.000511	0.00102	CcSEcCtD
Adenosine—Dermatitis—Epirubicin—sarcoma	0.00051	0.00102	CcSEcCtD
Adenosine—Headache—Epirubicin—sarcoma	0.000507	0.00101	CcSEcCtD
Adenosine—Dizziness—Doxorubicin—sarcoma	0.000496	0.000991	CcSEcCtD
Adenosine—Nausea—Epirubicin—sarcoma	0.000481	0.000962	CcSEcCtD
Adenosine—Vomiting—Doxorubicin—sarcoma	0.000476	0.000953	CcSEcCtD
Adenosine—Rash—Doxorubicin—sarcoma	0.000472	0.000945	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—sarcoma	0.000472	0.000944	CcSEcCtD
Adenosine—Headache—Doxorubicin—sarcoma	0.000469	0.000939	CcSEcCtD
Adenosine—Nausea—Doxorubicin—sarcoma	0.000445	0.00089	CcSEcCtD
